The clinical research currently consists of the following: Small 1980s pilot trials No large modern RCTs Limited pharmacokinetic clarity No validated subcutaneous dosing protocol for improved sleep DSIP likely works for many individuals, but its critical to acknowledge the doses used by the biohacking community comes from extrapolation
Benefits: Boosts mental clarity and focus Improves cellular energy production Supports anti-aging and longevity A great tool for those experiencing brain fog, fatigue, or looking to optimize cognitive performance
Semaglutide has a long half-life of approximately seven days
The primary difference between mobile and in-clinic IV therapy is convenience
Discard the supernatant and resuspend the cells with stimulation buffer to a density of 0.6 million cells per mL, then add the cells to 384-well white plates (3,000 cells per well)
In 2020, semaglutide was the 129th most commonly prescribed medication in the United States, with more than 4 million prescriptions